Financial News
Articles published by Vor Biopharma
Vor Bio to Participate in the Stifel 2024 Healthcare Conference
November 12, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Appoints Seasoned Healthcare Institutional Investor, Han Choi, M.D., LL.M., as Chief Financial Officer
September 30, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
September 05, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio to Participate in Upcoming Investor Conferences
August 28, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio to Participate in Upcoming Investor Conferences
April 01, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
March 20, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio to Participate in Upcoming Investor Conferences
March 04, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 02, 2024
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 21, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 01, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference
November 09, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Vor Bio to Participate in Upcoming Investor Conferences
November 03, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Multiple Clinical and Preclinical Presentations at ASH 2023 Highlight Vor Bio’s Novel eHSC and CAR-T Platform
November 02, 2023
From Vor Biopharma
Via GlobeNewswire
Tickers
VOR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.